Brought to you by 
Sepracor completes $165mm offering of convertible debentures
13 Jul 1999
Executive Summary
Public company Sepracor (chiral chemistry) has completed a $165mm offering of convertible subordinated debentures due 2005. The 6.25% debentures will be converted into common stock at $47.36 per share, redeemable in three years.
Deal Industry
- Biotechnology
-
Pharmaceuticals
- Chiral Chemistry
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sepracor completes $165mm offering of convertible debentures
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice